Literature DB >> 17593896

Reporting of systematic reviews: the challenge of genetic association studies.

Muin J Khoury, Julian Little, Julian Higgins, John P A Ioannidis, Marta Gwinn.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17593896      PMCID: PMC1896206          DOI: 10.1371/journal.pmed.0040211

Source DB:  PubMed          Journal:  PLoS Med        ISSN: 1549-1277            Impact factor:   11.069


× No keyword cloud information.
We applaud PLoS editors for their commitment to publishing high-quality systematic reviews (SRs) [1]. Moher et al. [2] clearly documented the inconsistent quality of reporting of SRs. With more than 2,500 SRs published every year, low-quality or outdated reviews may mislead researchers, providers, and policy makers. The situation could be improved if more evidence-based reporting guidelines were agreed upon, developed, and adhered to. The growing field of genetic associations (GAs) illustrates the urgent need for transparent SRs and meta-analyses. Already, thousands of articles on GAs have been published, and the application of high-throughput genotyping methods may exponentially increase the number of reported associations [3]. Selective reporting of large numbers of false-positive associations could undermine the field and interfere with our ability to translate advances in genomics into clinical practice. To address these problems, the Human Genome Epidemiology Network (HuGENet) was started as a global collaboration to strengthen methods of analysis and reporting of GAs and to develop a reliable knowledge base on the association between genetic variation and human diseases [4]. Between 2001 and 2006, the HuGENet online database assembled more than 25,000 published articles on GAs and more than 500 systematic reviews of GAs. Nevertheless, there are large inconsistencies in the quality of genetic association studies [5] and in the reporting of SRs of such associations [6]. In collaboration with several journals, HuGENet promotes the publication of transparently reported SRs of gene–disease associations [4]. More than 50 HuGE reviews have been published over the past six years. After several HuGENet workshops bringing together researchers from different fields and journal editors, the first edition of a HuGENet handbook, modeled in part after the Cochrane handbook of systematic reviews, was published on the Canadian HuGENet Web site [7]. The handbook describes methodological issues and outlines steps in conducting such reviews, including the need for a detailed protocol. It also discusses meta-analysis methods. We strongly encourage researchers interested in conducting systematic reviews of GAs to consult the HuGENet handbook, and adopt transparent protocols. Retrospective SRs of published data have limitations, even when properly conducted. Investigators can advance the field of human genome epidemiology by conducting prospective meta-analyses and large collaborative analyses through international consortia. HuGENet has created a Network of Investigator Networks to help the growth of such initiatives [8].
  6 in total

1.  Clinical epidemiological quality in molecular genetic research: the need for methodological standards.

Authors:  S T Bogardus; J Concato; A R Feinstein
Journal:  JAMA       Date:  1999-05-26       Impact factor: 56.272

Review 2.  Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology.

Authors:  John Attia; Ammarin Thakkinstian; Catherine D'Este
Journal:  J Clin Epidemiol       Date:  2003-04       Impact factor: 6.437

Review 3.  On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies.

Authors:  Muin J Khoury; Julian Little; Marta Gwinn; John P A Ioannidis
Journal:  Int J Epidemiol       Date:  2006-12-20       Impact factor: 7.196

4.  Many reviews are systematic but some are more transparent and completely reported than others.

Authors: 
Journal:  PLoS Med       Date:  2007-03       Impact factor: 11.069

5.  Epidemiology and reporting characteristics of systematic reviews.

Authors:  David Moher; Jennifer Tetzlaff; Andrea C Tricco; Margaret Sampson; Douglas G Altman
Journal:  PLoS Med       Date:  2007-03-27       Impact factor: 11.069

6.  A road map for efficient and reliable human genome epidemiology.

Authors:  John P A Ioannidis; Marta Gwinn; Julian Little; Julian P T Higgins; Jonine L Bernstein; Paolo Boffetta; Melissa Bondy; Molly S Bray; Paul E Brenchley; Patricia A Buffler; Juan Pablo Casas; Anand Chokkalingam; John Danesh; George Davey Smith; Siobhan Dolan; Ross Duncan; Nelleke A Gruis; Patricia Hartge; Mia Hashibe; David J Hunter; Marjo-Riitta Jarvelin; Beatrice Malmer; Demetrius M Maraganore; Julia A Newton-Bishop; Thomas R O'Brien; Gloria Petersen; Elio Riboli; Georgia Salanti; Daniela Seminara; Liam Smeeth; Emanuela Taioli; Nic Timpson; Andre G Uitterlinden; Paolo Vineis; Nick Wareham; Deborah M Winn; Ron Zimmern; Muin J Khoury
Journal:  Nat Genet       Date:  2006-01       Impact factor: 38.330

  6 in total
  7 in total

1.  Disease and phenotype gene set analysis of disease-based gene expression in mouse and human.

Authors:  Supriyo De; Yongqing Zhang; John R Garner; S Alex Wang; Kevin G Becker
Journal:  Physiol Genomics       Date:  2010-08-03       Impact factor: 3.107

Review 2.  Tilting at quixotic trait loci (QTL): an evolutionary perspective on genetic causation.

Authors:  Kenneth M Weiss
Journal:  Genetics       Date:  2008-08       Impact factor: 4.562

Review 3.  Genetic association studies in nursing practice and scholarship.

Authors:  Patricia C Underwood; Catherine Y Read
Journal:  J Nurs Scholarsh       Date:  2008       Impact factor: 3.176

4.  A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement.

Authors:  J A Hollenbach; S J Mack; P-A Gourraud; R M Single; M Maiers; D Middleton; G Thomson; S G E Marsh; M D Varney
Journal:  Tissue Antigens       Date:  2011-11

Review 5.  Expectations, validity, and reality in pharmacogenetics.

Authors:  Nita A Limdi; David L Veenstra
Journal:  J Clin Epidemiol       Date:  2009-12-07       Impact factor: 6.437

Review 6.  Promises and challenges of pharmacogenetics: an overview of study design, methodological and statistical issues.

Authors:  Stephanie Ross; Sonia S Anand; Philip Joseph; Guillaume Paré
Journal:  JRSM Cardiovasc Dis       Date:  2012-04-05

7.  What is the impact of PCSK9 rs505151 and rs11591147 polymorphisms on serum lipids level and cardiovascular risk: a meta-analysis.

Authors:  Chengfeng Qiu; Pingyu Zeng; Xiaohui Li; Zhen Zhang; Bingjie Pan; Zhou Y F Peng; Yapei Li; Yeshuo Ma; Yiping Leng; Ruifang Chen
Journal:  Lipids Health Dis       Date:  2017-06-12       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.